Predicted to enable bisphosphoglycerate 2-phosphatase activity and fructose-2,6-bisphosphate 2-phosphatase activity. Predicted to be involved in several processes, including fructose 1,6-bisphosphate metabolic process; negative regulation of cell death; and regulation of phosphate metabolic process. Predicted to act upstream of or within several processes, including fructose 2,6-bisphosphate metabolic process; negative regulation of catabolic process; and positive regulation of cardiac muscle cell apoptotic process. Predicted to be located in cytosol; mitochondrial outer membrane; and nucleus. Orthologous to human TIGAR (TP53 induced glycolysis regulatory phosphatase); INTERACTS WITH 6-propyl-2-thiouracil; acetamide; bisphenol A.
fructose-2,6-bisphosphatase TIGAR; hypothetical protein LOC502894; LOC502894; TP53-induced glycolysis and apoptosis regulator; uncharacterized protein LOC502894
[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TIGAR mRNA
1-Methyl-4-phenylpyridinium results in increased expression of TIGAR mRNA, 1-Methyl-4-phenylpyridinium results in increased expression of TIGAR protein
[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TIGAR mRNA
[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TIGAR mRNA